New book by Larry Connors Click here Improve your trading - See how
(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO)
"I am pleased to welcome John to our team," said Dr. Bruno. "Patient enrollment is the backbone of the clinical development process, ensuring that clinical trials adhere to timelines and include the proper patients to produce scientifically valid results. John's extensive expertise and standing as a thought leader in the patient enrollment arena will serve our customers well."
The addition of Needham strengthens Kendle's position as an industry leader in the development of global patient enrollment strategies. Kendle has been an innovator in developing best practices in patient recruitment and retention, hosting a series of international patient recruitment forums bringing together top experts from around the world to collaborate and define best practices. The result is one of the clinical development industry's only thought leadership groups dedicated exclusively to the advancement of innovative patient recruitment techniques and strategies. As a thought leader in the industry, Needham will be instrumental in leading the Company's ongoing commitment to this initiative.
Needham has more than 30 years of industry experience, including more than 20 years in senior leadership roles focused on patient enrollment. Most recently he served as founder and CEO of Needham and Company, a patient recruitment consulting firm he established in 2004. Prior to founding his own company, Needham served as Senior Director at Johnson and Johnson Pharmaceutical Research and Development where he was responsible for global recruitment strategy. His experience also includes co-founding and serving as general manager of PatientQuest, a clinical trial market research firm, as well as senior leadership roles for Acurian, Telerx Marketing, Telespectrum Worldwide and PharmaKinetics Laboratories.
Needham holds a bachelor's degree in marketing from Villanova University and is a graduate of the United States Naval War College. He served for three decades in the United States Navy Reserve reaching the rank of Captain, and is the recipient of three Navy Achievement Medals, three Navy Commendation Medals, one Meritorious Service Medal and one Legion of Merit Medal.
Kendle has been recognized by several leading industry organizations for the quality of its patient recruitment programs. The Company won a 2007 Silver Award for "Innovation in Patient Communication" from the Institute of Practitioners in Advertising, was a finalist for "Most Innovative Patient Recruitment Campaign" at the 2007 GCPj Awards, and has won multiple industry awards for study advertising in a variety of therapeutic areas, including asthma, allergy, ulcerative colitis, lupus and HIV-associated diarrhea.
Innovative patient recruitment strategies in support of recruitment at the investigative sites have in turn earned Kendle consistent recognition as the CRO of choice. The Company is the only CRO to be ranked consistently among the top two CROs to work with in the 2009, 2008 and 2007 CenterWatch surveys of U.S. and European investigative sites, including the top overall ranking in 2007.
About Kendle
Kendle International Inc. (Nasdaq: KNDL | Quote | Chart | News | PowerRating) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.
SOURCE Kendle International Inc.
http://www.kendle.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
